New medical research suggests that GLP-1 receptor agonists, commonly used for weight loss and diabetes, may reduce the risk of erectile dysfunction. The hosts view this as the final stage of a massive marketing campaign for the drugs, which have already been linked to reduced risks for heart attacks, alcoholism, and smoking.




